Drug Information

Drug General Information
Drug ID
D0S5YC
Former ID
DNC013581
Drug Name
MEPTAZINOL
Drug Type
Small molecular drug
Indication Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Approved [551871]
Formula
C15H24ClNO
Canonical SMILES
CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O
InChI
1S/C15H23NO/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13/h6-8,11,17H,3-5,9-10,12H2,1-2H3
InChIKey
JLICHNCFTLFZJN-UHFFFAOYSA-N
CAS Number
CAS 54340-58-8
PubChem Compound ID
65483
SuperDrug ATC ID
N02AX05
Target and Pathway
Target(s) Cholinesterase Target Info Inhibitor [529368]
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
WikiPathways Irinotecan Pathway
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 529368J Med Chem. 2008 Apr 10;51(7):2027-36. Epub 2008 Mar 12.Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.